References
- Cancer Registry of Norway. Cancer in Norway 2018 - Cancer incidence, m., survival and prevalence inNorway. Oslo: Cancer Registry of Norway; 2019.
- Mols F, Vingerhoets AJJM, Coebergh JW, et al. Quality of life among long-term breast cancer survivors: a systematic review. Eur J Cancer. 2005;41(17):2613–2619.
- Sagen A, Kåresen R, Sandvik L, et al. Changes in arm morbidities and health-related quality of life after breast cancer surgery - a five-year follow-up study. Acta Oncol. 2009;48(8):1111–1118.
- Segerström K, Bjerle P, Nyström A. Importance of time in assessing arm and hand function after treatment of breast cancer. Scand J Plast Reconstr Surg Hand Surg. 1991;25(3):241–244.
- Bentzen SM, Overgaard M, Thames HD. Fractionation sensitivity of a functional endpoint: impaired shoulder movement after post-mastectomy radiotherapy. Int J Radiat Oncol Biol Phys. 1989;17(3):531–537.
- Nesvold I-L, Reinertsen KV, Fosså SD, et al. The relation between arm/shoulder problems and quality of life in breast cancer survivors: a cross-sectional and longitudinal study. J Cancer Surviv. 2011;5(1):62–72.
- Thomas-Maclean RL, Hack T, Kwan W, et al. Arm morbidity and disability after breast cancer: new directions for care. Oncol Nurs Forum. 2008;35(1):65–71.
- Moody JA, Botham SJ, Dahill KE, et al. Complications following completion lymphadenectomy versus therapeutic lymphadenectomy for melanoma - a systematic review of the literature. Eur J Surg Oncol. 2017;43(9):1760–1767.
- Litrowski N, Duval Modeste A-B, Coquerel D, et al. Complication of radical lymph node dissection following sentinel lymph node biopsy in patients with melanoma. Ann Dermatol Venereol. 2013;140(6-7):425–430.
- Ul-Mulk J, Hölmich LR. Lymph node dissection in patients with malignant melanoma is associated with high risk of morbidity. Dan Med J. 2012;59(6):A4441.
- Renner P, Torzewski M, Zeman F, et al. Increasing morbidity with extent of lymphadenectomy for primary malignant melanoma. Lymphat Res Biol. 2017;15(2):146–152.
- van Akkooi ACJ, Bouwhuis MG, van Geel AN, et al. Morbidity and prognosis after therapeutic lymph node dissections for malignant melanoma. Eur J Surg Oncol. 2007;33(1):102–108.
- McLaughlin SA, Wright MJ, Morris KT, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors. J Cin Oncol. 2008;26(32):5220–5226.
- Hayes SC, Janda M, Cornish B, et al. Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. J Clin Oncol. 2008;26(21):3536–3542.
- Tsai RJ, Dennis LK, Lynch CF, et al. The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol. 2009;16(7):1959–1972.
- Starritt EC, Joseph D, McKinnon JG, et al. Lymphedema after complete axillary node dissection for melanoma: assessment using a new, objective definition. Ann Surg. 2004;240(5):866–874.
- Gullestad HP. Axillary lymph node dissection from Norway: Plastic Surgery Resident/American Society of Plastic Surgeons. Issue 8, Fall 2017.
- Finnerud MC, Heli-Haugestøl AG. Guidelines for physiotherapy rehabilitation after axillary nodal dissection in Melanoma. Department of Clinical Service. The Norwegian Hospital, Oslo University Hospital. 2018.
- Kwan W, Jackson J, Weir LM, et al. Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. J Cin Oncol. 2002;20(20):4242–4248.
- Nesvold I-L, Fosså SD, Naume B, et al. Kwan's arm problem scale: psychometric examination in a sample of stage II breast cancer survivors. Breast Cancer Res Treat. 2009;117(2):281–288.
- Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–376.
- Dickson PV, Gershenwald JE. Staging and prognosis of cutaneous melanoma. Surg Oncol Clin N Am. 2011;20(1):1–17.
- Silberman AW, McVay C, Cohen JS, et al. Comparative morbidity of axillary lymph node dissection and the sentinel lymph node technique: implications for patients with breast cancer. Ann Surg. 2004;240(1):1–6.
- Soares EWS, Nagai HM, Bredt LC, et al. Morbidity after conventional dissection of axillary lymph nodes in breast cancer patients. World J Surg Onc. 2014;12(1):67.
- Nesvold I-L, Dahl AA, Løkkevik E, et al. Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy. Acta Oncol. 2008;47(5):835–842.